Prior approval / prescription requirement

Therapy must be prescribed by the attending physician as part of the written care plan and provided by a qualified licensed professional (physician, psychologist, physical therapist, occupational therapist, and/or speech therapist). Ongoing services require documentation demonstrating continued objective improvement in function as identified in short- and long-term goals; maintenance programs without potential for improvement are not considered medically necessary.

• Prescribe cognitive rehabilitation in a written care plan signed/dated by the attending physician (chunk 15).
• Ensure services are delivered by a qualified licensed professional (physician, psychologist, PT, OT, and/or speech therapist) (chunks 15, 17).
• For ongoing/maintenance services, include objective measures showing continued improvement; maintenance without demonstrated improvement is not medically necessary (chunk 19).
• Note: cognitive rehabilitation is investigational for indications other than TBI (chunk 16).

See Codes table

Refer to the Codes table and report services using the specified CPT/HCPCS codes when billing cognitive rehabilitation services; use documentation to support medical necessity and chosen codes.

• See Codes table for details and code descriptions (chunk 21).
• Use CPT 97129 (initial 15 minutes) and 97130 (each additional 15 minutes), and HCPCS S9056 for coma stimulation per diem where applicable (chunk 163).
• Include supporting clinical documentation to justify use of the reported codes (chunk 163).

Prior authorization for individualized cognitive rehabilitation

If prior authorization is sought for individualized cognitive rehabilitation, include that the intervention is individualized, delivered by a qualified professional, the therapeutic plan (number/frequency/duration), targeted goals, and planned outcome assessment interval (follow-up).

• Describe the individualized nature of the program and clinician qualifications (chunk 48).
• Provide the written care plan and session schedule (number/frequency/duration) as part of the request (chunk 15).
• State planned outcome measures and follow-up timing (e.g., baseline validated screening and follow-up at ~6 months; longer follow-up may be needed for PASC) (chunks 96, 104).

Prior authorization

No specific prior authorization process is specified in this policy excerpt; verify payer-specific prior authorization requirements separately.

• Policy lists 'Prior approval: Not applicable' but still requires physician prescription and documentation (chunks 12, 15).
• Confirm any regional or payer-specific prior authorization procedures outside this policy before submitting claims (chunk 69).

Prior authorization expectation

When programs claim durable cognitive benefit, prior authorization or review may require evidence of clinically meaningful, sustained improvement given limited high-quality long-term evidence.

• Provide objective outcome data showing sustained improvement if requesting long-term or maintenance coverage (chunks 78, 39).
• Large, high-quality trials demonstrating durable benefit are lacking; plan for reviewers to request longitudinal outcome evidence (chunk 90).

Assessment and follow-up documentation

Document baseline cognitive assessment with validated screening tools (e.g., MoCA or MMSE) and plan for follow-up assessment at approximately 6 months; longer follow-up (1–2 years) may be necessary for some conditions such as PASC.

• Record baseline validated test results (MoCA or MMSE) prior to initiating therapy (chunk 96).
• Schedule and document follow-up assessments at ~6 months to evaluate outcomes; for PASC consider 1–2 year follow-up to demonstrate efficacy (chunks 96, 39).
• Include pre/post objective measures in the medical record to support continued services (chunk 104).

Prior authorization recommended

Prior authorization is recommended to include evidence of clinically significant cognitive deficits, a description of the cognitive rehabilitation program (frequency, duration, techniques), and planned outcome measures because trials vary and often have short follow-up.

• Provide documentation of clinically significant deficits measured by validated tests and the indication for therapy (chunk 116).
• Detail treatment modality, session frequency/duration, and therapeutic techniques used (chunk 48).
• Specify objective pre/post outcome measures and planned follow-up intervals (chunk 90).

Referral and program requirements

Referral to a specialist (speech-language pathologist, occupational therapist, neuropsychologist) or documentation of a trial of clinician-directed cognitive rehabilitation is recommended for persistent cognitive deficits after evaluating and addressing reversible contributors.

• Refer patients who screen positive to specialists with expertise in cognitive assessment and remediation (chunk 135).
• VA guidance recommends referral for a short trial of clinician-directed cognitive rehabilitation when symptoms persist despite management of contributing factors (chunk 142).
• Document prior clinician-directed rehabilitation trials and rationale for further therapy (chunk 48).

Code reporting requirement

Report cognitive therapeutic interventions using CPT 97129 (initial 15 minutes) and 97130 (each additional 15 minutes); use HCPCS S9056 for coma stimulation per diem where applicable.

• CPT 97129: Therapeutic interventions focused on cognitive function; initial 15 minutes (chunk 163).
• CPT 97130: Each additional 15 minutes (List separately) (chunk 163).
• HCPCS S9056: Coma stimulation per diem (chunk 163).

Code reporting requirement

Claims should be submitted with the appropriate CPT/HCPCS codes (e.g., 97129, 97130, S9056) and supported by documentation that demonstrates medical necessity and aligns with the billed codes.

• Ensure clinical documentation (diagnosis, baseline measures, treatment plan, progress notes) supports the level and duration of billed services (chunk 163).
• Use the Codes table and payer guidelines to verify coding and submission requirements (chunk 21).

Therapy visit limits

When cognitive rehabilitation is performed by PT/OT/speech therapists as outpatient services, those visits count toward any applicable therapy visit limits in the subscriber contract.

• Confirm subscriber contract therapy visit limits prior to scheduling (chunk 17).
• Document services per outpatient rehabilitation guidelines to ensure correct application to visit limits (chunk 17).

Comparator treatments

When evaluating need or prior authorization, consider standard rehabilitation without specific cognitive focus or no rehabilitation as comparators; document prior trials of standard rehabilitation if relevant.

• State whether the patient has undergone standard PT/OT or other non-cognitive rehabilitation and the clinical response (chunk 28).
• Document rationale for selecting cognitive rehabilitation versus standard rehabilitation or observation (chunks 38, 95).

Comparator considerations

Consider prior trials of standard rehabilitation approaches when evaluating requests for cognitive rehabilitation and document these in the medical record; comparators include standard rehab or no rehabilitation.

• Include documentation of prior standard rehabilitation efforts and outcomes (chunk 38).
• If no prior standard rehabilitation was attempted, provide clinical justification for initiating cognitive rehabilitation (chunk 28).

No step therapy rules specified

No step therapy protocols or mandatory stepwise requirements are specified in this policy; comparators considered include standard rehabilitation without cognitive focus or no rehabilitation.

• There are no described step therapy rules in this section—verify payer-specific step protocols if applicable (chunks 64, 119).
• Comparators include standard PT/OT without cognitive focus or no rehabilitation (chunk 77).

Position relative to standard rehabilitation

When positioning cognitive rehabilitation relative to standard rehabilitation, document why cognitive-focused therapy is indicated rather than or in addition to standard PT/OT/SLP without cognitive focus.

• Explain clinical rationale for cognitive focus (e.g., specific attention, memory, executive deficits) and prior response to standard rehabilitation (chunks 74, 77).
• Include targeted functional goals that differ from general rehabilitation aims (chunk 74).

Comparator therapies

When documenting prior therapies, clarify prior use of standard rehabilitation approaches and whether cognitive-specific techniques were attempted; this informs comparator assessment.

• List prior rehabilitation types, dates, and outcomes to show necessity of cognitive-specific intervention (chunk 95).
• Document why cognitive rehabilitation is expected to provide benefit beyond prior standard therapies (chunk 28).

Step therapy protocols

No step therapy protocols are described in this section of the policy.

• If a payer requires step therapy, verify and follow the payer's step protocol; this policy does not define one (chunk 119).

Address reversible contributors first

Before or concurrently with cognitive rehabilitation, evaluate and treat reversible contributors to cognitive symptoms (sleep, mood, pain, endocrine issues, and polypharmacy) and consider deprescribing medications that may impair cognition.

• Perform medication review and consider polypharmacy reduction/deprescribing when feasible (chunk 135).
• Assess and address sleep disturbance, mood disorders, pain, and other medical contributors per AAPM&R guidance (chunks 133, 135).
• Document evaluation and treatment of reversible factors in the medical record prior to or during cognitive rehabilitation (chunk 137).

Required documentation and goals

Therapy must be prescribed as part of a written care plan that documents the indication, baseline deficits, targeted functional and quality-of-life goals, and shows potential for improvement; ongoing services must document objective progress toward goals.

• Include diagnosis, baseline cognitive/functional measures, identified deficits, and individualized therapy plan in the written care plan (chunk 15).
• State short- and long-term measurable goals and criteria for demonstrating improvement (chunks 62, 66).
• For ongoing therapy, provide serial objective measures demonstrating progress (chunk 15).

Documentation of objective functional improvement

Document baseline and objective functional measures and demonstrate continued objective improvement for ongoing or maintenance therapy; maintenance without potential for improvement is not medically necessary.

• Record baseline objective functional measures and use standardized outcome measures to track progress (chunk 19).
• Maintenance therapy must show objective evidence of continued improvement to be considered medically necessary (chunks 19, 23).
• If goals are met and no further progress is expected, note that services transition to maintenance and may not be covered (chunk 19).

Documentation specifics

Documentation should include diagnosis (e.g., dementia or other CNS-related cognitive deficit), baseline cognitive/functional measures (MMSE or equivalent), identified individualized goals targeted by therapy, number and frequency of sessions, and follow-up outcomes when available.

• Include diagnosis and validated baseline cognitive test scores (MMSE, MoCA) (chunks 45, 48).
• Specify individualized goals, session counts/frequency, and maintenance schedule if used (chunks 45, 48).
• When available, include follow-up outcomes up to 24 months for dementia-related programs (chunk 45).

Documentation of provider qualification and diagnosis

Document that cognitive deficits are due to a central nervous system insult (e.g., stroke, TBI) and that therapy is delivered by a qualified provider with details of targeted domains and intervention components.

• State the CNS-related diagnosis and link specific cognitive deficits to that diagnosis (chunk 64).
• Document provider type and qualifications who deliver cognitive rehabilitation (chunk 15).
• Describe the intervention components (retraining, compensatory strategies) and targeted cognitive domains (attention, memory, language, executive function) (chunk 66).

Suggested documentation and follow-up

Include baseline deficits, functional and quality-of-life goals, planned follow-up (ideally using validated tools), and describe how progress will be measured.

• List baseline cognitive deficits and specific functional/QOL goals (chunk 66).
• Plan follow-up assessments, ideally up to 6–12 months or longer when indicated, using validated instruments (chunks 78, 96).
• Document intended objective measures to track progress over time (chunk 96).

Required documentation and outcome measurement

Required documentation should include validated screening tool results (MoCA or MMSE), evaluation for reversible contributors (sleep, mood, endocrine, medications), thorough neurologic history/exam, and planned follow-up of at least 6 months to demonstrate outcomes.

• Use validated screening tools (MoCA or MMSE) and include scores in the record (chunk 96).
• Document evaluation and management of reversible contributors per AAPM&R recommendations (sleep, mood, medication review) (chunk 133).
• Plan and record follow-up assessments at ~6 months (or longer where specified) to support efficacy claims (chunks 96, 97).

Recommended supporting documentation

Provide supporting documentation of indication, validated test results showing cognitive deficits, treatment modality and duration, and objective pre/post outcome measures, as many trials report only short-term or nonstandard outcomes.

• Include validated test results demonstrating deficits and baseline function (chunk 116).
• Detail the treatment modality, duration, and session structure (chunk 121).
• Provide objective pre/post measures to support claims of benefit given heterogeneous trial outcomes (chunk 125).

Required clinical documentation for assessment

Document screening results with validated tools, evaluate for reversible contributors (sleep, mood, endocrine, medications), perform a neurologic exam, obtain collateral history, and include standardized measures of activity performance to guide treatment and follow-up.

• Conduct standardized screening and include results in the chart (chunk 133).
• Perform medication review and consider deprescribing where feasible (chunk 137).
• Obtain collateral history and standardized activity performance measures to quantify functional status (chunk 137).

Required coding documentation

Use the appropriate CPT, HCPCS, Revenue, and ICD diagnosis codes when reporting services; ensure documentation supports the selected codes and billed time units.

• Report cognitive therapeutic interventions with CPT 97129 (initial 15 minutes) and 97130 (each additional 15 minutes) consistent with documented time and services (chunk 163).
• Use HCPCS S9056 for coma stimulation per diem where appropriate and ensure clinical documentation justifies its use (chunk 163).
• Include ICD diagnosis codes that reflect the CNS-related cognitive deficit to substantiate medical necessity (chunk 163).

Required coding documentation

Report services with the listed CPT/HCPCS codes and ensure place-of-service and revenue codes are consistent with the setting; documentation must support the use of therapeutic intervention codes 97129/97130 or HCPCS S9056 as applicable.

• Align billed codes (97129/97130, S9056) with the documented modality, duration, and place of service (chunk 163).
• Verify coding requirements in the Codes table and payer submission guidance (chunk 21).

Investigational indications may be denied

Cognitive rehabilitation is considered investigational (not covered) for indications other than traumatic brain injury (examples: dementia, MS, stroke, PASC, epilepsy, cancer-related deficits, coma stimulation), so services for those indications may be denied.

• Do not expect coverage for outpatient cognitive rehabilitation for listed investigational indications absent compelling documentation of individualized benefit (chunk 16).

Maintenance therapy and continued improvement

Services billed as maintenance therapy may be considered not medically necessary unless documentation demonstrates continued objective improvement in function; maintenance begins when therapeutic goals are achieved or no further progress is expected.

• Provide objective evidence of ongoing improvement if billing for continued/maintenance services (chunk 19).
• If goals have been met and only maintenance is provided, expect potential noncoverage (chunk 15).

Evidence selection implications for authorization

Studies with duplicative or overlapping populations were excluded from the evidence base; documentation or program materials that lack distinct, nonoverlapping participant evidence may affect authorization or favorable coverage decisions.

• Ensure program evaluation and outcome data are specific to distinct populations and not duplicative of published cohorts when submitting evidence for authorization (chunk 40).

Evidence limitations may affect coverage

Insufficient high-quality evidence of durable, clinically significant cognitive improvement may lead to denial for long-term claims where the intent is durable cognitive restoration rather than short-term or goal-specific gains.

• Be prepared to provide longitudinal objective outcomes if requesting coverage for programs claiming durable restoration (chunks 90, 125).
• Short-term or domain-limited improvements may not justify long-term coverage without demonstrated sustained functional benefit (chunk 78).

Insufficient evidence may lead to coverage denial

Randomized trials have methodological limitations and lack consistent durable benefits; absence of strong evidence may trigger denials when clinical benefit is not demonstrated.

• Provide rigorous outcome data and justification for clinical relevance when seeking authorization (chunk 125).
• Recognize that guideline panels and reviews note mixed or low-certainty evidence for many indications (chunk 90).

Insufficient evidence may affect coverage

Guidelines note insufficient evidence for specific cognitive rehabilitation methodologies for some conditions (e.g., stroke), which could lead to denial when specific techniques are requested without demonstrated functional benefit.

• When requesting technique-specific interventions, include evidence or rationale showing functional benefit for the patient’s condition (chunk 141).
• Document how the selected methodology addresses functional deficits after stroke or other conditions with limited guideline support (chunk 72).

Coding-based denial risk

Billing without the specified CPT/HCPCS codes (e.g., 97129, 97130, S9056) or without documentation to support code selection may lead to claim processing issues or denials.

• Use CPT 97129/97130 for direct cognitive therapeutic interventions and HCPCS S9056 for coma stimulation per diem as appropriate (chunk 163).
• Ensure documentation justifies billed time units and service descriptions to avoid coding-based denials (chunk 163).

Coding and billing requirements

Use appropriate CPT, HCPCS, Revenue, and ICD diagnosis codes to report services; failing to use correct codes or to document support for code use may result in claim denial or processing problems.

• Verify code selection against the Codes table and local payer billing rules prior to claim submission (chunk 21).
• Ensure ICD diagnosis codes correspond to the documented CNS-related cognitive impairment to substantiate medical necessity (chunk 163).